Evaluation of stroke volume surrogates using a wearable doppler ultrasound patch to monitor fluid responsiveness in severe burns: an observational study

The Defense Health Agency (DHA), through the Military Medical Research and Development program (CFDA 12.420), awarded $2.134M to Flosonics Medical (1929803 Ontario Corp) on July 1, 2025, for an observational research study evaluating stroke volume surrogates using a wearable Doppler ultrasound patch to monitor fluid responsiveness in severe burns. The two-year project, with completion targeted for June 30, 2027, and based at the awardee's facility in Ottawa, Ontario, Canada, represents an investment in advanced biomedical technology development relevant to military medical needs.

This award supports research aimed at developing and validating novel diagnostic tools for critical care applications, specifically addressing the clinical challenge of assessing fluid responsiveness in severely burned patients. The wearable ultrasound patch technology represents the type of innovative diagnostic intervention prioritized under the Military Medical Research and Development program, which funds research from early-stage exploratory work through mature clinical applications to transform healthcare for military service members and the broader public.